Specific contribution of P19ARF to nitric oxide-dependent apoptosis

被引:32
|
作者
Zeini, Miriam
Traves, Paqui G.
Lopez-Fontal, Raquel
Pantoja, Cristina
Matheu, Ander
Serrano, Manuel
Bosca, Lisardo
Hortelano, Sonsoles
机构
[1] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain
[2] Spanish Natl Canc Ctr, Madrid, Spain
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 177卷 / 05期
关键词
ARF TUMOR-SUPPRESSOR; NF-KAPPA-B; P53-DEPENDENT APOPTOSIS; CHRONIC INFLAMMATION; TRANSCRIPTION FACTOR; P53; ACTIVATION; INK4A LOCUS; MDM2; GENE; MACROPHAGES;
D O I
10.4049/jimmunol.177.5.3327
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NO is an important bioactive molecule involved in a variety of physio- and pathological processes, including apoptosis induction. The proapoptotic activity of NO involves the rise in the tumor suppressor p53 and the accumulation and targeting of proapoptotic members of the Bcl-2 family, in particular Bax and the release of cytochrome c from the mitochondria. However, the exact mechanism by which NO induces p53 activation has not been fully elucidated. In this study, we describe that NO induces p19(ARF) through a transcriptional mechanism. This up-regulation of P19(ARF) activates p53, leading to apoptosis. The importance of p19(ARF) on NO-dependent apoptosis was revealed by the finding that various cell types from alternate reading frame-knockout mice exhibit a diminished response to NO-mediated apoptosis when compared with normal mice. Moreover, the biological relevance of afternative reading frame to p53 apoptosis was confirmed in in vivo models of apoptosis. Together, these results demonstrate that NO-dependent apoptosis requires, in part, the activation of P19(ARF).
引用
收藏
页码:3327 / 3336
页数:10
相关论文
共 50 条
  • [32] Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras
    Young, Nathan P.
    Jacks, Tyler
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) : 10184 - 10189
  • [33] Nucleophosmin is required for DNA integrity and p19Arf protein stability
    Colombo, E
    Bonetti, P
    Denchi, EL
    Martinelli, P
    Zamponi, R
    Marine, JC
    Helin, K
    Falini, B
    Pelicci, PG
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (20) : 8874 - 8886
  • [34] p16Ink4a and p19Arf:: terrible twins
    Weitzman, JB
    TRENDS IN MOLECULAR MEDICINE, 2001, 7 (11) : 489 - 489
  • [35] A novel role for the p19ARF tumor suppressor in chromosome segregation
    Britigan, Eric M. C.
    Weaver, Beth A.
    CANCER RESEARCH, 2012, 72
  • [36] p19Arf cooperation in Shp2-induced lelukemogenesis
    Chen, Xiaolan
    Huang, Yuhui
    Yan, Ling
    Wang, Zhizhang
    Brault, Marie
    Thompson, Maryann
    Yang, Elizabeth
    BLOOD, 2007, 110 (11) : 483A - 483A
  • [37] p19Arf Cooperates with Shp2 in Lymphoid Leukemogenesis
    Chen, Xiaolan
    Huang, Yuhui
    Yan, Ling
    Brault, Marie
    Wang, Zhizhang
    Arildsen, Maryann T.
    Yang, Elizabeth
    BLOOD, 2008, 112 (11) : 1302 - 1302
  • [38] p19Arf is required for the cellular response to chronic DNA damage
    K T Bieging-Rolett
    T M Johnson
    C A Brady
    V G Beaudry
    N Pathak
    S Han
    L D Attardi
    Oncogene, 2016, 35 : 4414 - 4421
  • [39] The genetic polymorphism in p19Arf confers resistance to tumor progression
    Saito, Megumi
    Okumura, Kazuhiro
    Isogai, Eriko
    Araki, Kimi
    Wakabayashi, Yuichi
    CANCER SCIENCE, 2018, 109 : 437 - 437
  • [40] p19Arf represses Pdgfrβ-driven pericyte proliferation in vivo
    Widau, Ryan C.
    Zeliyianskaia, Anna
    Skapek, Stephen X.
    CANCER RESEARCH, 2011, 71